Comparison of Efficacy and Safety between Long-Acting Injectable Antipsychotic Monotherapy and Combination of Long-Acting Injectable and Oral Antipsychotics in Patients with Schizophrenia

BACKGROUND: Long-acting injectable (LAI) antipsychotics are used as a monotherapy in patients with schizophrenia. However, the combination of LAI and oral antipsychotics is commonly used in clinical practice, despite there being very limited studies investigating the efficacy and safety of this comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathienluckana, Thanompong, Tiangpattanawong, Pornyupa, Chaiyasukthananoan, Karnpreena, Jittayanan, Pannapat, Sawetwangsing, Hathaipat, Puchsaka, Punyawee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639247/
https://www.ncbi.nlm.nih.gov/pubmed/34868682
http://dx.doi.org/10.1155/2021/8403986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639247/
https://www.ncbi.nlm.nih.gov/pubmed/34868682
http://dx.doi.org/10.1155/2021/8403986

Ejemplares similares